Clinical Reminders in Test Reports to Improve Guideline Compliance
NCT00414401 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1500
Last updated 2015-04-07
Summary
Although beta-blockers are known to prolong survival for patients with reduced left ventricular ejection fraction, their use in the community and the VA is suboptimal.
Conditions
- Heart Failure, Congestive
Interventions
- BEHAVIORAL
-
Clinical Reminder
Sponsors & Collaborators
-
US Department of Veterans Affairs
lead FED
Principal Investigators
-
Paul A. Heidenreich, MD MS · VA Palo Alto Health Care System, Palo Alto, CA
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-05-31
- Completion
- 2006-06-30
Countries
- United States
Study Locations
More Related Trials
-
Use of Beta Blockers in Elderly Trauma Patients
NCT00302692 ·Status: UNKNOWN ·Phase: PHASE2
-
Real-world Use and Prognosis of Beta Blocker in Patients With Acute Coronary Syndrome in the Central China
NCT03116854 ·Status: COMPLETED
-
Real World Assessment of Effects of Beta-blockers on Patients With Acute Coronary Syndrome
NCT03669991 ·Status: UNKNOWN
-
Impact of Beta Blockers on TAVI (BETA-TAVI)
NCT05721170 ·Status: RECRUITING ·Phase: PHASE4
-
Pharmacodynamic Study of Carvedilol Versus Metoprolol in Heart Failure
NCT00802230 ·Status: COMPLETED ·Phase: PHASE4
-
Beta-2 Polymorphisms and Beta Receptor Selectivity
NCT00214318 ·Status: COMPLETED ·Phase: NA
-
The Influence of Beta Blocker Therapy on the Hemodynamic Response to Inotrope Infusion in Patients With Acute Decompensated Heart Failure
NCT01971944 ·Status: COMPLETED
-
Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
NCT06964464 ·Status: RECRUITING ·Phase: PHASE4
-
Pulse Reduction On Beta-blocker and Ivabradine Therapy
NCT02973594 ·Status: COMPLETED ·Phase: PHASE4
-
Beta-blocker Before Extubation
NCT00563238 ·Status: WITHDRAWN ·Phase: NA
-
Beta2-adrenergic System and Training
NCT04616261 ·Status: UNKNOWN ·Phase: NA
-
Effect of Beta Blockade on Left Ventricular Remodeling and Function in Moderate to Severe Asymptomatic Aortic Regurgitation
NCT01157572 ·Status: COMPLETED ·Phase: PHASE4
-
Nesiritide Therapy to Preserve Function of the Left Ventricle After Myocardial Infarction
NCT00573144 ·Status: COMPLETED ·Phase: PHASE2
-
Carvedilol in HF With Preserved EF
NCT05553314 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of 2 Beta Blocker Drugs on Peripheral Arterial Disease in Patients With High Blood Pressure
NCT01499134 ·Status: COMPLETED ·Phase: PHASE3
-
Genetic Determinants of Response to Beta Blockade
NCT00837902 ·Status: COMPLETED ·Phase: NA
-
The Contemporary Role of Beta Blockers in Patients With Acute Myocardial Infarction
NCT04564365 ·Status: UNKNOWN
-
Effects of Beta-Blocker Therapy and Phosphodiesterase Inhibition on Cardiac Neurohormonal Activation
NCT00348101 ·Status: COMPLETED ·Phase: PHASE3
-
24 Hour Ambulatory Cardiac Oxygen Consumption
NCT05170061 ·Status: COMPLETED ·Phase: PHASE3
-
De-Adoption of Beta-Blockers in Patients With Stable Ischemic Heart Disease
NCT05081999 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
A Pilot Study Comparing Nebivolol and Atenolol and Its Effects With Exercise in Patients With Mild to Moderate Hypertension
NCT00200421 ·Status: COMPLETED ·Phase: PHASE2
-
Nebivolol Versus Metoprolol: Comparative Effects on Fatigue and Quality of Life
NCT00999102 ·Status: COMPLETED ·Phase: PHASE4
-
Beta-blockers in i-PAH
NCT01246037 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Comparative Effects of Nebivolol and Metoprolol on Female Sexual Function
NCT00995072 ·Status: COMPLETED ·Phase: NA
-
Effect of Beta-blockers on Structural Remodeling and Gene Expression in the Failing Human Heart
NCT01798992 ·Status: COMPLETED ·Phase: PHASE4